Transthyretin
From Proteopedia
| Line 6: | Line 6: | ||
==3D structures of transthyretin== | ==3D structures of transthyretin== | ||
| + | |||
| + | ''Updated December 2011'' | ||
[[2pab]], [[1tta]], [[1ttb]], [[1etb]], [[1bmz]], [[1f41]], [[1dvq]], [[1fh2]], [[1qwh]], [[2h4e]], [[2qgb]], [[3cbr]], [[3d7p]], [[3cfm]], [[3i9p]], [[3a4d]], [[3a4e]], [[3a4f]] – hTTR – human | [[2pab]], [[1tta]], [[1ttb]], [[1etb]], [[1bmz]], [[1f41]], [[1dvq]], [[1fh2]], [[1qwh]], [[2h4e]], [[2qgb]], [[3cbr]], [[3d7p]], [[3cfm]], [[3i9p]], [[3a4d]], [[3a4e]], [[3a4f]] – hTTR – human | ||
| - | [[1eta]], [[1ttc]], [[1tsh]], [[2trh]], [[2try]], [[1bzd]], [[1bze]], [[1fhn]], [[ | + | [[1eta]], [[1ttc]], [[1tsh]], [[2trh]], [[2try]], [[1bzd]], [[1bze]], [[1fhn]], [[1g1o]], [[1x7s]], [[2qel]], [[3dgd]], [[3did]], [[3kgs]] – hTTR (amyloidogenic mutant) |
[[1ttr]] – hTTR (cardiomyapatic mutant) | [[1ttr]] – hTTR (cardiomyapatic mutant) | ||
| Line 29: | Line 31: | ||
[[1tlm]] – hTTR + milrinone | [[1tlm]] – hTTR + milrinone | ||
| - | [[1bm7]] – hTTR + flufenamic acid | + | [[1bm7]], [[3ozi]] – hTTR + flufenamic acid |
| - | [[1dvs]], [[1dvt]], [[1dvu]], [[1dvx]], [[1dvy]], [[1dvz]], [[1tt6]], [[1tz8]], [[2f8i]], [[2fbr, [[2flm, [[2g5u]], [[2g9k]], [[2gab]], [[2qgc]], [[2qgd]], [[2qge]], [[3cn0]], [[3cn1]], [[3cn2]], [[3cn3]], [[3cn4]], [[3esn]], [[3eso]], [[3esp]], [[3glz]], [[3gs0]], [[3gs4]], [[3gs7]], [[3imr]], [[3ims]], [[3imt]], [[3imu]], [[3imv]], [[3imw]], [[3ipb]], [[3ipe]], [[3m10]] – hTTR + amyloid disease inhibitor | + | [[1dvs]], [[1dvt]], [[1dvu]], [[1dvx]], [[1dvy]], [[1dvz]], [[1tt6]], [[1tz8]], [[2f8i]], [[2fbr, [[2flm, [[2g5u]], [[2g9k]], [[2gab]], [[2qgc]], [[2qgd]], [[2qge]], [[3cn0]], [[3cn1]], [[3cn2]], [[3cn3]], [[3cn4]], [[3esn]], [[3eso]], [[3esp]], [[3glz]], [[3gs0]], [[3gs4]], [[3gs7]], [[3imr]], [[3ims]], [[3imt]], [[3imu]], [[3imv]], [[3imw]], [[3ipb]], [[3ipe]], [[3m10]], [[2fbr]], [[2flm]], [[3m1o]] – hTTR + amyloid disease inhibitor |
[[1u21]], [[3cfn]], [[3cfq]], [[3cft]], [[3hj0]], [[3nee]], [[3neo]], [[3p3r]], [[3p3s]], [[3p3t]], [[3p3u]] – hTTR + inhibitor | [[1u21]], [[3cfn]], [[3cfq]], [[3cft]], [[3hj0]], [[3nee]], [[3neo]], [[3p3r]], [[3p3s]], [[3p3t]], [[3p3u]] – hTTR + inhibitor | ||
| Line 49: | Line 51: | ||
[[1kgi]] – rTTR + tetraiodotyroacetic acid | [[1kgi]] – rTTR + tetraiodotyroacetic acid | ||
| - | [[ | + | [[1z7i]] - hTTR + tetraiodotyroacetic acid |
[[1kgj]] – rTTR + dibromoflavone | [[1kgj]] – rTTR + dibromoflavone | ||
| Line 55: | Line 57: | ||
[[1zcr]], [[1zd6]] – hTTR + anion | [[1zcr]], [[1zd6]] – hTTR + anion | ||
| - | [[1y1d]], [[2b77]], [[2b9a]], [[3d2t]], [[3fc8]], [[3fcb]] – hTTR + diflunisal derivative | + | [[1y1d]], [[2b77]], [[2b9a]], [[3d2t]], [[3fc8]], [[3fcb]], [[2f7i]] – hTTR + diflunisal derivative |
[[3b56]] – hTTR + salicylic acid derivative | [[3b56]] – hTTR + salicylic acid derivative | ||
Revision as of 08:38, 21 December 2011
Template:STRUCTURE 1rlb
Transthyretin (TTR) is a serum carrier ot the thyroid hormone thyroxine (T4) and retinol through its association with retinol-binding protein (RBP). Many small molecules bind to TTR T4-binding site. TTR is known to be associated with amyloid diseases.
Contents |
3D structures of transthyretin
Updated December 2011
2pab, 1tta, 1ttb, 1etb, 1bmz, 1f41, 1dvq, 1fh2, 1qwh, 2h4e, 2qgb, 3cbr, 3d7p, 3cfm, 3i9p, 3a4d, 3a4e, 3a4f – hTTR – human
1eta, 1ttc, 1tsh, 2trh, 2try, 1bzd, 1bze, 1fhn, 1g1o, 1x7s, 2qel, 3dgd, 3did, 3kgs – hTTR (amyloidogenic mutant)
1ttr – hTTR (cardiomyapatic mutant)
1bz8, 5ttr, 1f86, 1gko, 1iii, 1iik, 1ijn, 1sok, 1soq, 1x7t, 2g3x, 2g3z, 2g4e, 2g4g, 2noy, 3bt0, 3cxf, 3djr, 3djs, 3djt, 3djz, 3dk0, 3dk2, 3do4, 3gps, 3grb, 3grg, 3i9a, 3i9i – hTTR (mutant)
1tfp – TTR – chicken
2qpf – TTR - mouse
1oo2, 1sn2 – gsTTR – gilthead seabream
1gke – rTTR – rat
TTR binary complexes
1thc, 2h1x, 2h6u – hTTR + hydroxyaurone derivative
1tlm – hTTR + milrinone
1bm7, 3ozi – hTTR + flufenamic acid
1dvs, 1dvt, 1dvu, 1dvx, 1dvy, 1dvz, 1tt6, 1tz8, 2f8i, [[2fbr, [[2flm, 2g5u, 2g9k, 2gab, 2qgc, 2qgd, 2qge, 3cn0, 3cn1, 3cn2, 3cn3, 3cn4, 3esn, 3eso, 3esp, 3glz, 3gs0, 3gs4, 3gs7, 3imr, 3ims, 3imt, 3imu, 3imv, 3imw, 3ipb, 3ipe, 3m10, 2fbr, 2flm, 3m1o – hTTR + amyloid disease inhibitor
1u21, 3cfn, 3cfq, 3cft, 3hj0, 3nee, 3neo, 3p3r, 3p3s, 3p3t, 3p3u – hTTR + inhibitor
1e3f, 1e4h, 1e5a, 2b15 – hTTR + phenol derivative
2b14, 2b16 – hTTR (mutant) + phenol derivative
3kgt, 3kgu – hTTR (mutant) + genistein
3ng5 – hTTR (mutant) + epigallocatechin gallate
3nes, 3nex – hTTR (mutant) + inhibitor
1tyr – hTTR + retinoic acid
1kgi – rTTR + tetraiodotyroacetic acid
1z7i - hTTR + tetraiodotyroacetic acid
1kgj – rTTR + dibromoflavone
1y1d, 2b77, 2b9a, 3d2t, 3fc8, 3fcb, 2f7i – hTTR + diflunisal derivative
3b56 – hTTR + salicylic acid derivative
TTR complexes with retinol-binding protein
2wqa – hTTR + RBP + oleic acid
3bsz – hTTR + RBP + antibody
TTR complexes with thyroxine
3ozk – hTTR (mutant) + T4
1tha, 2roy – hTTR + T4 derivative
1ie4 – rTTR + T4
1sn0 – gsTTR + T4
1sn5 – gsTTR + T4 derivative
